Sue Gail Eckhardt - Insider Trading & Ownership

Entity
Individual
Location
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, Cambridge, MA
Summary
The estimated net worth of Sue Gail Eckhardt is at least $790K dollars as of June 7, 2024. Sue Gail Eckhardt is the Director of EXELIXIS, INC. and owns shares of EXELIXIS, INC. (EXEL) stock worth about $711K. Sue Gail Eckhardt is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $79.2K.
All Insider Reports
All Insider Reports

Ownership of Sue Gail Eckhardt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EXEL EXELIXIS, INC. Director $711K May 31, 2024
SYRS Syros Pharmaceuticals, Inc. Director $79.2K Jun 5, 2024

Insider Transactions Reported by Sue Gail Eckhardt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.